During the past decade, The Center For Pharmaceutical Research conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 46 clinical trials were completed, i.e. on average, 102.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 23 clinical trials were completed. i.e. 230% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Center For Pharmaceutical Research" #1 sponsor was "Pfizer" with 20 trials, followed by "Emergent BioSolutions" with 8 trials sponsored, "Janssen Vaccines & Prevention B.V." with 6 trials sponsored, "Purdue Pharma LP" with 4 trials sponsored and "Seqirus" with 4 trials sponsored. Other sponsors include 66 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Center For Pharmaceutical Research" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Coalition for Epidemic Preparedness Innovations" with 2 trials as a collaborator and "Department of Health and Human Services" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "The Center For Pharmaceutical Research" are "Influenza" (8 trials), "Smoking Cessation" (8 trials), "Osteoarthritis, Knee" (5 trials), "Healthy" (4 trials) and "Alzheimer Disease" (3 trials). Many other conditions were trialed in "The Center For Pharmaceutical Research" in a lesser frequency.

Most popular intervention types in "The Center For Pharmaceutical Research" are "Drug" (72 trials), "Biological" (40 trials), "Other" (15 trials), "Device" (8 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (49 trials), "Rimegepant" (5 trials), "placebo" (5 trials), "Bapineuzumab 0.5 mg/kg" (3 trials) and "Buprenorphine transdermal delivery system" (3 trials). Other intervention names were less common.

The vast majority of trials in "The Center For Pharmaceutical Research" are 110 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Center For Pharmaceutical Research". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 94 completed trials in The Center For Pharmaceutical Research, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in The Center For Pharmaceutical Research, 11 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 4 trials that are defined as “Not Applicable".